当前位置: 首页 >> 检索结果
共有 539 条符合本次的查询结果, 用时 4.684564 秒

101. Genetic Association Analyses Highlight IL6, ALPL, and NAV1 As 3 New Susceptibility Genes Underlying Calcific Aortic Valve Stenosis.

作者: Sébastien Thériault.;Christian Dina.;David Messika-Zeitoun.;Solena Le Scouarnec.;Romain Capoulade.;Nathalie Gaudreault.;Sidwell Rigade.;Zhonglin Li.;Floriane Simonet.;Maxime Lamontagne.;Marie-Annick Clavel.;Benoit J Arsenault.;Anne-Sophie Boureau.;Simon Lecointe.;Estelle Baron.;Stéphanie Bonnaud.;Matilde Karakachoff.;Eric Charpentier.;Imen Fellah.;Jean-Christian Roussel.;Jean Philippe Verhoye.;Christophe Baufreton.;Vincent Probst.;Ronan Roussel.; .;Richard Redon.;François Dagenais.;Philippe Pibarot.;Patrick Mathieu.;Thierry Le Tourneau.;Yohan Bossé.;Jean-Jacques Schott.
来源: Circ Genom Precis Med. 2019年12卷10期e002617页
Calcific aortic valve stenosis (CAVS) is a frequent and life-threatening cardiovascular disease for which there is currently no medical treatment available. To date, only 2 genes, LPA and PALMD, have been identified as causal for CAVS. We aimed to identify additional susceptibility genes for CAVS.

102. Effects of Percutaneous Coronary Intervention on Death and Myocardial Infarction Stratified by Stable and Unstable Coronary Artery Disease: A Meta-Analysis of Randomized Controlled Trials.

作者: Liza Chacko.;James P Howard.;Christopher Rajkumar.;Alexandra N Nowbar.;Christopher Kane.;Dina Mahdi.;Michael Foley.;Matthew Shun-Shin.;Graham Cole.;Sayan Sen.;Rasha Al-Lamee.;Darrel P Francis.;Yousif Ahmad.
来源: Circ Cardiovasc Qual Outcomes. 2020年13卷2期e006363页
In patients presenting with ST-segment-elevation myocardial infarction, percutaneous coronary intervention (PCI) reduces mortality when compared with fibrinolysis. In other forms of coronary artery disease (CAD), however, it has been controversial whether PCI reduces mortality. In this meta-analysis, we examine the benefits of PCI in (1) patients post-myocardial infarction (MI) who did not receive immediate revascularization; (2) patients who have undergone primary PCI for ST-segment-elevation myocardial infarction but have residual coronary lesions; (3) patients who have suffered a non-ST-segment-elevation acute coronary syndrome; and (4) patients with truly stable CAD with no recent infarct. This analysis includes data from the recently presented International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) and Complete versus Culprit-Only Revascularization Strategies to Treat Multivessel Disease after Early PCI for STEMI (COMPLETE) trials.

103. Prognostic Significance of Left Ventricular Noncompaction: Systematic Review and Meta-Analysis of Observational Studies.

作者: Nay Aung.;Sara Doimo.;Fabrizio Ricci.;Mihir M Sanghvi.;Cesar Pedrosa.;Simon P Woodbridge.;Amer Al-Balah.;Filip Zemrak.;Mohammed Y Khanji.;Patricia B Munroe.;Huseyin Naci.;Steffen E Petersen.
来源: Circ Cardiovasc Imaging. 2020年13卷1期e009712页
Although left ventricular noncompaction (LVNC) has been associated with an increased risk of adverse cardiovascular events, the accurate incidence of cardiovascular morbidity and mortality is unknown. We, therefore, aimed to assess the incidence rate of LVNC-related cardiovascular events.

104. Major Adverse Cardiovascular Events Associated With Postoperative Atrial Fibrillation After Noncardiac Surgery: A Systematic Review and Meta-Analysis.

作者: Ahmed AlTurki.;Mariam Marafi.;Riccardo Proietti.;Daniela Cardinale.;Robert Blackwell.;Paul Dorian.;Amal Bessissow.;Lucy Vieira.;Isabelle Greiss.;Vidal Essebag.;Jeff S Healey.;Thao Huynh.
来源: Circ Arrhythm Electrophysiol. 2020年13卷1期e007437页
Postoperative atrial fibrillation (POAF) is a frequent occurrence after noncardiac surgery. It remains unclear whether POAF is associated with an increased risk of major adverse events. We aimed to elucidate the risk of stroke, myocardial infarction, and death associated with POAF following noncardiac surgery by a meta-analysis of randomized controlled studies and observational studies.

105. The Effect of Coconut Oil Consumption on Cardiovascular Risk Factors: A Systematic Review and Meta-Analysis of Clinical Trials.

作者: Nithya Neelakantan.;Jowy Yi Hoong Seah.;Rob M van Dam.
来源: Circulation. 2020年141卷10期803-814页
Coconut oil is high in saturated fat and may, therefore, raise serum cholesterol concentrations, but beneficial effects on other cardiovascular risk factors have also been suggested. Therefore, we conducted a systematic review of the effect of coconut oil consumption on blood lipids and other cardiovascular risk factors compared with other cooking oils using data from clinical trials.

106. Individual Lesion-Level Meta-Analysis Comparing Various Doses of Intracoronary Bolus Injection of Adenosine With Intravenous Administration of Adenosine for Fractional Flow Reserve Assessment.

作者: Gilbert W M Wijntjens.;Ellen L van Uffelen.;Mauro Echavarría-Pinto.;Lorena Casadonte.;Valérie E Stegehuis.;Tadashi Murai.;Koen M J Marques.;Myeong-Ho Yoon.;Seung-Jea Tahk.;Gianni Casella.;Antonio M Leone.;Ramón López Palop.;Christian Schlundt.;Fernando Rivero.;Ricardo Petraco.;William F Fearon.;Nils P Johnson.;Allen Jeremias.;Bon-Kwon Koo.;Jan J Piek.;Tim P van de Hoef.
来源: Circ Cardiovasc Interv. 2020年13卷1期e007893页
Intravenous infusion of adenosine is considered standard practice for fractional flow reserve (FFR) assessment but is associated with adverse side-effects and is time-consuming. Intracoronary bolus injection of adenosine is better tolerated by patients, cheaper, and less time-consuming. However, current literature remains fragmented and modestly sized regarding the equivalence of intracoronary versus intravenous adenosine. We aim to investigate the relationship between intracoronary adenosine and intravenous adenosine to determine FFR.

107. Dietary Cholesterol and Cardiovascular Risk: A Science Advisory From the American Heart Association.

作者: Jo Ann S Carson.;Alice H Lichtenstein.;Cheryl A M Anderson.;Lawrence J Appel.;Penny M Kris-Etherton.;Katie A Meyer.;Kristina Petersen.;Tamar Polonsky.;Linda Van Horn.; .
来源: Circulation. 2020年141卷3期e39-e53页
The elimination of specific dietary cholesterol target recommendations in recent guidelines has raised questions about its role with respect to cardiovascular disease. This advisory was developed after a review of human studies on the relationship of dietary cholesterol with blood lipids, lipoproteins, and cardiovascular disease risk to address questions about the relevance of dietary cholesterol guidance for heart health. Evidence from observational studies conducted in several countries generally does not indicate a significant association with cardiovascular disease risk. Although meta-analyses of intervention studies differ in their findings, most associate intakes of cholesterol that exceed current average levels with elevated total or low-density lipoprotein cholesterol concentrations. Dietary guidance should focus on healthy dietary patterns (eg, Mediterranean-style and DASH [Dietary Approaches to Stop Hypertension]-style diets) that are inherently relatively low in cholesterol with typical levels similar to the current US intake. These patterns emphasize fruits, vegetables, whole grains, low-fat or fat-free dairy products, lean protein sources, nuts, seeds, and liquid vegetable oils. A recommendation that gives a specific dietary cholesterol target within the context of food-based advice is challenging for clinicians and consumers to implement; hence, guidance focused on dietary patterns is more likely to improve diet quality and to promote cardiovascular health.

108. Outcomes With Deferred Versus Performed Revascularization of Coronary Lesions With Gray-Zone Fractional Flow Reserve Values.

作者: Michael Megaly.;Charl Khalil.;Marwan Saad.;Iosif Xenogiannis.;Mohamed Omer.;Mahesh Anantha Narayanan.;Ashish Pershad.;Santiago Garcia.;Arnold H Seto.;M Nicholas Burke.;Emmanouil S Brilakis.
来源: Circ Cardiovasc Interv. 2019年12卷12期e008315页
Management of coronary lesions with fractional flow reserve values in the gray zone (0.75-0.80) remains controversial due to conflicting data on the performance versus deferral of revascularization.

109. Peri-Infarct Quantification by Cardiac Magnetic Resonance to Predict Outcomes in Ischemic Cardiomyopathy: Prognostic Systematic Review and Meta-Analysis.

作者: Hourmazd Haghbayan.;Nick Lougheed.;Djeven P Deva.;Kelvin K W Chan.;João A C Lima.;Andrew T Yan.
来源: Circ Cardiovasc Imaging. 2019年12卷11期e009156页
In ischemic cardiomyopathy, cardiac magnetic resonance assessment of the peri-infarct zone, a potential substrate for arrhythmogenesis, may serve as a novel prognosticator and guide the optimal use of implantable cardioverter-defibrillators. We undertook a systematic review and meta-analysis assessing the prognostic value of the peri-infarct zone on late gadolinium enhancement cardiac magnetic resonance in ischemic cardiomyopathy.

110. Optimal Strategy and Timing of Left Ventricular Venting During Veno-Arterial Extracorporeal Life Support for Adults in Cardiogenic Shock: A Systematic Review and Meta-Analysis.

作者: Abdulrahman A Al-Fares.;Varinder K Randhawa.;Marina Englesakis.;Michael A McDonald.;A Dave Nagpal.;Jerry D Estep.;Edward G Soltesz.;Eddy Fan.
来源: Circ Heart Fail. 2019年12卷11期e006486页
Veno-arterial extracorporeal life support (VA-ECLS) is widely used to treat refractory cardiogenic shock. However, increased left ventricular (LV) afterload in VA-ECLS can worsen pulmonary congestion and compromise myocardial recovery. Our objectives were to explore the efficacy, safety, and optimal timing of adjunctive LV venting strategies.

111. Incorporation of Biomarkers Into Risk Assessment for Allocation of Antihypertensive Medication According to the 2017 ACC/AHA High Blood Pressure Guideline: A Pooled Cohort Analysis.

作者: Ambarish Pandey.;Kershaw V Patel.;Wanpen Vongpatanasin.;Colby Ayers.;Jarett D Berry.;Robert J Mentz.;Michael J Blaha.;John W McEvoy.;Paul Muntner.;Muthiah Vaduganathan.;Adolfo Correa.;Javed Butler.;Daichi Shimbo.;Vijay Nambi.;Christopher deFilippi.;Stephen L Seliger.;Christie M Ballantyne.;Elizabeth Selvin.;James A de Lemos.;Parag H Joshi.
来源: Circulation. 2019年140卷25期2076-2088页
Risk for atherosclerotic cardiovascular disease was a novel consideration for antihypertensive medication initiation in the 2017 American College of Cardiology/American Heart Association Blood Pressure (BP) guideline. Whether biomarkers of chronic myocardial injury (high-sensitivity cardiac troponin T ≥6 ng/L] and stress (N-terminal pro-B-type natriuretic peptide [NT-proBNP] ≥100 pg/mL) can inform cardiovascular (CV) risk stratification and treatment decisions among adults with elevated BP and hypertension is unclear.

112. Antiarrhythmic Drugs or Catheter Ablation in the Management of Ventricular Tachyarrhythmias in Patients With Implantable Cardioverter-Defibrillators: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

作者: Babikir Kheiri.;Mahmoud Barbarawi.;Yazan Zayed.;Michael Hicks.;Mohammed Osman.;Laith Rashdan.;Htay Htay Kyi.;Ghassan Bachuwa.;Mustafa Hassan.;Eric C Stecker.;Babak Nazer.;Deepak L Bhatt.
来源: Circ Arrhythm Electrophysiol. 2019年12卷11期e007600页
In patients with an implantable cardioverter-defibrillator (ICD), shocks are associated with increased morbidity and mortality. Therefore, we conducted this study to evaluate the efficacy and safety of antiarrhythmic drugs and catheter ablation (CA) in the treatment of ventricular tachyarrhythmias (VT) in patients with an ICD.

113. Integration of Large-Scale Genomic Data Sources With Evolutionary History Reveals Novel Genetic Loci for Congenital Heart Disease.

作者: Elisavet Fotiou.;Simon Williams.;Alexandra Martin-Geary.;David L Robertson.;Gennadiy Tenin.;Kathryn E Hentges.;Bernard Keavney.
来源: Circ Genom Precis Med. 2019年12卷10期442-451页
Most cases of congenital heart disease (CHD) are sporadic and nonsyndromic, with poorly understood etiology. Rare genetic variants have been found to affect the risk of sporadic, nonsyndromic CHD, but individual studies to date are of only moderate sizes, and none to date has incorporated the ohnolog status of candidate genes in the analysis. Ohnologs are genes retained from ancestral whole-genome duplications during evolution; multiple lines of evidence suggest ohnologs are overrepresented among dosage-sensitive genes. We integrated large-scale data on rare variants with evolutionary information on ohnolog status to identify novel genetic loci predisposing to CHD.

114. Remote Magnetic Versus Manual Catheter Navigation for Atrial Fibrillation Ablation: A Meta-Analysis.

作者: Sohaib A Virk.;Saurabh Kumar.
来源: Circ Arrhythm Electrophysiol. 2019年12卷10期e007517页

115. Dog Ownership and Survival: A Systematic Review and Meta-Analysis.

作者: Caroline K Kramer.;Sadia Mehmood.;Renée S Suen.
来源: Circ Cardiovasc Qual Outcomes. 2019年12卷10期e005554页
Dog ownership has been associated with decreased cardiovascular risk. Recent reports have suggested an association of dog companionship with lower blood pressure levels, improved lipid profile, and diminished sympathetic responses to stress. However, it is unclear if dog ownership is associated with improved survival as previous studies have yielded inconsistent results. Thus, we performed a systematic review and meta-analysis to evaluate the association of dog ownership with all-cause mortality, with and without prior cardiovascular disease, and cardiovascular mortality.

116. Mortality Assessment of Paclitaxel-Coated Balloons: Patient-Level Meta-Analysis of the ILLUMENATE Clinical Program at 3 Years.

作者: William A Gray.;Michael R Jaff.;Sahil A Parikh.;Gary M Ansel.;Marianne Brodmann.;Prakash Krishnan.;Mahmood K Razavi.;Frank Vermassen.;Thomas Zeller.;Roseann White.;Kenneth Ouriel.;Mark A Adelman.;Sean P Lyden.
来源: Circulation. 2019年140卷14期1145-1155页
A recent summary-level meta-analysis comprising randomized, controlled trials (RCTs) of femoropopliteal paclitaxel-coated balloon and stent intervention identified excess late mortality in the paclitaxel-treated patients.

117. Association Between Triglyceride Lowering and Reduction of Cardiovascular Risk Across Multiple Lipid-Lowering Therapeutic Classes: A Systematic Review and Meta-Regression Analysis of Randomized Controlled Trials.

作者: Nicholas A Marston.;Robert P Giugliano.;KyungAh Im.;Michael G Silverman.;Michelle L O'Donoghue.;Stephen D Wiviott.;Brian A Ference.;Marc S Sabatine.
来源: Circulation. 2019年140卷16期1308-1317页
Randomized trials of therapies that primarily lowered triglycerides have not consistently shown reductions in cardiovascular events.

118. Catheter Ablation Versus Medical Therapy for Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

作者: Zain Ul Abideen Asad.;Ali Yousif.;Muhammad Shahzeb Khan.;Sana M Al-Khatib.;Stavros Stavrakis.
来源: Circ Arrhythm Electrophysiol. 2019年12卷9期e007414页
Despite the publication of several randomized clinical trials comparing catheter ablation (CA) with medical therapy (MT) in patients with atrial fibrillation (AF), the superiority of one strategy over another is still questioned by many. In this meta-analysis of randomized controlled trials, we compared the efficacy and safety of CA with MT for AF.

119. Blood Pressure-Associated Genetic Variants in the Natriuretic Peptide Receptor 1 Gene Modulate Guanylate Cyclase Activity.

作者: Sara Vandenwijngaert.;Clara D Ledsky.;Najim Lahrouchi.;Mohsin A F Khan.;Florian Wunderer.;Lisa Ames.;Toshiyuki Honda.;John L Diener.;Connie R Bezzina.;Emmanuel S Buys.;Donald B Bloch.;Christopher Newton-Cheh.; .
来源: Circ Genom Precis Med. 2019年12卷8期e002472页
Human genetic variation in the NPR1 (natriuretic peptide receptor 1 gene, encoding NPR-A, atrial natriuretic peptide receptor 1) was recently shown to affect blood pressure (BP). NPR-A catalyzes the intracellular conversion of guanosine triphosphate to cGMP (cyclic 3',5'-guanosine monophosphate) on binding of ANP, BNP (atrial or brain natriuretic peptide). Increased levels of cGMP decrease BP by inducing natriuresis, diuresis, and vasodilation.

120. Blood Leukocyte DNA Methylation Predicts Risk of Future Myocardial Infarction and Coronary Heart Disease.

作者: Golareh Agha.;Michael M Mendelson.;Cavin K Ward-Caviness.;Roby Joehanes.;TianXiao Huan.;Rahul Gondalia.;Elias Salfati.;Jennifer A Brody.;Giovanni Fiorito.;Jan Bressler.;Brian H Chen.;Symen Ligthart.;Simonetta Guarrera.;Elena Colicino.;Allan C Just.;Simone Wahl.;Christian Gieger.;Amy R Vandiver.;Toshiko Tanaka.;Dena G Hernandez.;Luke C Pilling.;Andrew B Singleton.;Carlotta Sacerdote.;Vittorio Krogh.;Salvatore Panico.;Rosario Tumino.;Yun Li.;Guosheng Zhang.;James D Stewart.;James S Floyd.;Kerri L Wiggins.;Jerome I Rotter.;Michael Multhaup.;Kelly Bakulski.;Steven Horvath.;Philip S Tsao.;Devin M Absher.;Pantel Vokonas.;Joel Hirschhorn.;M Daniele Fallin.;Chunyu Liu.;Stefania Bandinelli.;Eric Boerwinkle.;Abbas Dehghan.;Joel D Schwartz.;Bruce M Psaty.;Andrew P Feinberg.;Lifang Hou.;Luigi Ferrucci.;Nona Sotoodehnia.;Giuseppe Matullo.;Annette Peters.;Myriam Fornage.;Themistocles L Assimes.;Eric A Whitsel.;Daniel Levy.;Andrea A Baccarelli.
来源: Circulation. 2019年140卷8期645-657页
DNA methylation is implicated in coronary heart disease (CHD), but current evidence is based on small, cross-sectional studies. We examined blood DNA methylation in relation to incident CHD across multiple prospective cohorts.
共有 539 条符合本次的查询结果, 用时 4.684564 秒